Veracyte, Inc. (VCYT)
40.14
-1.07
(-2.60%)
USD |
NASDAQ |
Sep 15, 16:00
40.64
+0.50
(+1.25%)
Pre-Market: 09:20
Veracyte Price to Book Value : 2.323 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.323 |
| September 14, 2026 | 2.385 |
| September 11, 2026 | 2.366 |
| September 10, 2026 | 2.433 |
| September 09, 2026 | 2.539 |
| September 08, 2026 | 2.457 |
| September 04, 2026 | 2.462 |
| September 03, 2026 | 2.586 |
| September 02, 2026 | 2.598 |
| September 01, 2026 | 2.514 |
| August 31, 2026 | 2.500 |
| August 28, 2026 | 2.509 |
| August 27, 2026 | 2.619 |
| August 26, 2026 | 2.564 |
| August 25, 2026 | 2.549 |
| August 24, 2026 | 2.400 |
| August 21, 2026 | 2.449 |
| August 20, 2026 | 2.419 |
| August 19, 2026 | 2.442 |
| August 18, 2026 | 2.355 |
| August 17, 2026 | 2.436 |
| August 14, 2026 | 2.388 |
| August 13, 2026 | 2.466 |
| August 12, 2026 | 2.586 |
| August 11, 2026 | 2.686 |
| Date | Value |
|---|---|
| August 10, 2026 | 2.678 |
| August 07, 2026 | 2.733 |
| August 06, 2026 | 2.671 |
| August 05, 2026 | 2.671 |
| August 04, 2026 | 2.686 |
| August 03, 2026 | 2.596 |
| July 31, 2026 | 2.681 |
| July 30, 2026 | 3.460 |
| July 29, 2026 | 3.225 |
| July 28, 2026 | 3.221 |
| July 27, 2026 | 3.219 |
| July 24, 2026 | 3.277 |
| July 23, 2026 | 3.350 |
| July 22, 2026 | 3.358 |
| July 21, 2026 | 3.446 |
| July 20, 2026 | 3.314 |
| July 17, 2026 | 3.423 |
| July 16, 2026 | 3.428 |
| July 15, 2026 | 3.445 |
| July 14, 2026 | 3.277 |
| July 13, 2026 | 3.327 |
| July 10, 2026 | 3.298 |
| July 09, 2026 | 3.432 |
| July 08, 2026 | 3.248 |
| July 07, 2026 | 3.251 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Teleflex, Inc. | 1.882 |
| West Pharmaceutical Services, Inc. | 8.593 |
| Globus Medical, Inc. | 2.103 |
| Illumina, Inc. | 11.83 |
| Twist Bioscience Corp. | 19.42 |
Price to Book Value Related Metrics
| PE Ratio | 28.48 |
| PS Ratio | 5.794 |
| PEG Ratio | 0.088 |
| Price to Free Cash Flow | 19.62 |
| Price | 40.14 |
| Earnings Yield | 3.51% |
| Market Cap | 3.226B |
| PEGY Ratio | 0.088 |
| Operating PE Ratio | 33.64 |
| Normalized PE Ratio | 31.11 |